ONWARD Medical, a leader in neurotechnology for spinal cord injury therapies, will announce its first quarter 2026 financial results on May 26, 2026. CEO Dave Marver will host a webcast to provide a detailed business update. The company is known for its ARC Therapy systems, including the commercially available ARC-EX and the investigational ARC-IM, which aims to address blood pressure instability and enable brain-computer interface integration. Investors and interested parties can register for the webcast and access replay materials afterward.
Strategy, a major Bitcoin treasury, added 24,869 BTC worth about $2 billion, raising its total holdings to 843,738 BTC. This purchase occurred near their average cost basis, suggesting a psychologically important price zone that may indicate a local ...
SERB Pharmaceuticals has acquired exclusive rights to develop and sell Idefirix (imlifidase), a treatment for highly sensitised kidney transplant patients, across Europe and the MENA region from Hansa Biopharma for €115 million. Idefirix helps reduce...
KITE led Upbit's crypto greed index with a score of 76 despite a 5.04% price drop to 339 won, signaling a cooling phase rather than a trend reversal. The token saw heavy trading volume (~15.06 billion won), indicating active repositioning amid sustai...
European stocks are set to open mixed following U.S. President Trump's announcement to postpone a planned attack on Iran after diplomatic requests from Middle Eastern leaders. Oil prices dropped, with Brent crude down over 2%, reflecting eased geopol...
XRP is consolidating near $1.30 after a three-day selloff, with traders closely monitoring if it can hold this critical support level. A breakdown below $1.30 could lead to further declines, while recovery depends on Bitcoin's stabilization and incre...
